SCHEMBL16811878

SCHEMBL16811878

Cc1c(C(=O)NC2CCN(Cc3ccc(N4CCC(NC(=O)c5cccc(-c6cccnc6)c5C)CC4)nc3)CC2)cccc1-c1cccnc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 1/20 0.72
▸ CXCR4 P61073 1/20 0.47
▸ DRD4 P21917 4/20 0.47
▸ POLB P06746 1/20 0.46
▸ CD274 Q9NZQ7 2/20 0.45
▸ SLC6A5 Q9Y345 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ CCR3 P51677 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ WNT1 P04628 1/20 0.44
▸ DYRK1A Q13627 1/20 0.44
▸ FLT3 P36888 1/20 0.44
▸ TYRO3 Q06418 1/20 0.44
▸ MERTK Q12866 1/20 0.44
▸ GAS6 Q14393 1/20 0.44
▸ SLC6A12 P48065 1/20 0.44
▸ PDCD1 Q15116 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16811782 0.97 SMO (0.68) SMOCXCR4DRD4POLBCD274
SCHEMBL15615023 0.96 SMO (0.66) SMOCXCR4DRD4POLBCD274
SCHEMBL16811913 0.96 SMO (0.66) SMOCXCR4DRD4POLBCD274
SCHEMBL16811801 0.95 SMO (0.73) SMOCXCR4DRD4POLBCD274
SCHEMBL16811888 0.95 SMO (0.66) SMOCXCR4DRD4POLBCD274
SCHEMBL16811884 0.95 SMO (0.66) SMOCXCR4DRD4POLBCD274
SCHEMBL16811876 0.95 SMO (0.66) SMOCXCR4DRD4POLBCD274
SCHEMBL16811881 0.95 SMO (0.66) SMOCXCR4DRD4POLBCD274
SCHEMBL16811910 0.95 SMO (0.65) SMOCXCR4DRD4POLBCD274
SCHEMBL15615029 0.95 SMO (0.65) SMOCXCR4DRD4POLBCD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885CXCR4 3485/4885DRD4 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback